MBBP Clients Red Crow and MiRTLE Medical Featured in Forbes Article Regarding New Equity Crowdfunding Platform

MBBP clients Red Crow and MiRTLE Medical are featured in a Forbes article regarding Red Crow's new equity crowdfunding portal that will be launching in November.  The crowdfunding platform will feature "exclusive and professionally-vetted investment opportunities" for accredited and non-accredited investors. MiRTLE Medical will have one of the first featured investment opportunities. MiRTLE's product is …

Continue reading MBBP Clients Red Crow and MiRTLE Medical Featured in Forbes Article Regarding New Equity Crowdfunding Platform

Panel 3 of Life Sciences Series To Be Held On September 22nd!

On Thursday, September 22nd, MBBP will host the third panel of our Life Sciences Series, "Funding Models in Biotech".  The panel will be held at the Cambridge Innovation Center (CIC) from 4:30pm - 6:00pm. The panel will discuss today's financing environment for emerging biotech companies, and the many complexities facing these companies in their attempts …

Continue reading Panel 3 of Life Sciences Series To Be Held On September 22nd!

Harvard Stem Cell Institute Teaming Up to Develop Diabetes Cure

A group of Boston-area health institutions, known as the Boston Autologous Islet Replacement Program, are teaming up to develop, test and deploy stem cells to cure diabetes. The group includes the Harvard Stem Cell Institute, Brigham and Women's Hospital, the Joslin Diabetes Center, Dana-Farber Cancer Institute and Semma Therapeutics. The innovation began when Doug Melton, Co-Director …

Continue reading Harvard Stem Cell Institute Teaming Up to Develop Diabetes Cure

Blue Stream Laboratories Acquired by Charles River Laboratories

MBBP client Blue Stream Laboratories, an analytical contract research organization supporting the development of complex biologics and biosimilars, was acquired by Charles River Laboratories. Charles River Laboratories is a provider of essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. …

Continue reading Blue Stream Laboratories Acquired by Charles River Laboratories

PULSE@Mass Challenge Now Open in Boston!

PULSE@MassChallenge officially opened in Boston last week, adding to the already increasing number of digital health companies in the area.  MBBP’s Peter Barnes-Brown attended the ribbon cutting ceremony. Read more about Peter's thoughts on the growing digital health industry and about the company on our VCs & Startups Blog.

Boston Growing Hub for the Life Sciences Industry

The Boston Business Journal just announced that at the annual Biotechnology Innovation Organization meeting, Boston was recognized as the city with the largest number of employers in the field of research testing and medical laboratories.  The BBJ explains that from biotech giants such as Biogen to Genzyme to research labs at the prestigious Harvard and MIT, …

Continue reading Boston Growing Hub for the Life Sciences Industry

MBBP Managing Partner Lisa Warren Panelist at MassBio Annual Meeting

On Thursday, March 26th MBBP Managing Partner Lisa Warren will sit as part of a panel at The MassBio Annual Meeting.  The discussion will be on the topic of Externalizing Pharma R&D. The MassBio Annual Meeting is a two day event that focuses on the most timely and critical challenges facing the Massachusetts biotechnology industry. As MassBio's …

Continue reading MBBP Managing Partner Lisa Warren Panelist at MassBio Annual Meeting

M&A Today: First Issue of 2015

We’re starting 2015 with plenty of M&A news! Articles include: Treasury Announces New Restrictions on Inversions Massachusetts Court (Sort of) Adopts Delaware’s Great Hill Holding Regarding the Attorney-Client Privilege in Mergers Scrutinizing Biotechnology & Software Patent Eligibility in M&A Deal Valuations Delaware Court Refuses to Enforce Indemnity & Release Provisions Against Non-Consenting Stockholder Open Source …

Continue reading M&A Today: First Issue of 2015

IntegraGen Opens Subsidiary in Cambridge

MBBP client IntegraGen, Inc., a French biotech company, announced it will be opening a U.S. subsidiary in Cambridge, Massachusetts which will help to conduct its clinical research initiatives on early identification of children at risk of autism. IntegraGen's corporate headquarters is located in Evry, France where it focuses on gene discovery and providing state of …

Continue reading IntegraGen Opens Subsidiary in Cambridge